Suppr超能文献

对遗传性肺泡蛋白沉积症家族的全基因组测序鉴定出一个罕见的结构变异,涉及 CSF2RA/CRLF2/IL3RA 基因缺失。

Whole-Genome Sequencing of a Family with Hereditary Pulmonary Alveolar Proteinosis Identifies a Rare Structural Variant Involving CSF2RA/CRLF2/IL3RA Gene Disruption.

机构信息

Department of Pediatrics, Chang Gung Memorial Hospital at Keelung, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

Division of Pediatric Pulmonology, Chang Gung Memorial Hospital, College of Medicine, Chang Gung University, Taoyuan, Taiwan.

出版信息

Sci Rep. 2017 Feb 24;7:43469. doi: 10.1038/srep43469.

Abstract

Pulmonary alveolar proteinosis (PAP) is a rare pulmonary disease in which the abnormalities in alveolar surfactant accumulation are caused by impairments of GM-CSF pathway attributing to defects in a variety of genes. However, hereditary PAP is extremely uncommon and a detailed understanding in the genetic inheritance of PAP in a family may provide timely diagnosis, treatment and proper intervention including genetic consultation. Here, we described a comprehensive analysis of genome and gene expression for a family containing one affected child with a diagnosis of PAP and two other healthy siblings. Family-based whole-genome analysis revealed a homozygous deletion that disrupts CSF2RA, CRLF2, and IL3RA gene in the pseudoautosomal region of the X chromosome in the affected child and one of asymptomatic siblings. Further functional pathway analysis of differentially expressed genes in IL-1β-treated peripheral blood mononuclear cells highlighted the insufficiency of immune response in the child with PAP, especially the protection against bacterial infection. Collectively, our results reveal a novel allele as the genetic determinant of a family with PAP and provide insights into variable expressivity and incomplete penetrance of this rare disease, which will be helpful for proper genetic consultation and prompt treatment to avoid mortality and morbidity.

摘要

肺泡蛋白沉积症(PAP)是一种罕见的肺部疾病,其肺泡表面活性物质积累异常是由 GM-CSF 途径的损伤引起的,归因于多种基因的缺陷。然而,遗传性 PAP 极为罕见,对家族中 PAP 的遗传进行详细了解可以提供及时的诊断、治疗和适当的干预,包括遗传咨询。在这里,我们描述了对一个包含一个确诊为 PAP 的患病儿童和两个其他健康兄弟姐妹的家庭进行的全基因组和基因表达的综合分析。基于家族的全基因组分析显示,患病儿童和无症状的一个兄弟姐妹的 X 染色体假常染色体区域的 CSF2RA、CRLF2 和 IL3RA 基因发生了纯合缺失。用白细胞介素 1β处理外周血单核细胞后的差异表达基因的功能途径分析突出了 PAP 患儿免疫反应不足,特别是对细菌感染的保护不足。总之,我们的结果揭示了一个新的等位基因作为 PAP 家族的遗传决定因素,并深入了解了这种罕见疾病的变异性表达和不完全外显率,这将有助于进行适当的遗传咨询和及时治疗,以避免死亡率和发病率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f1ff/5324064/2863d21ecb7e/srep43469-f1.jpg

相似文献

2
Hereditary pulmonary alveolar proteinosis: pathogenesis, presentation, diagnosis, and therapy.
Am J Respir Crit Care Med. 2010 Nov 15;182(10):1292-304. doi: 10.1164/rccm.201002-0271OC. Epub 2010 Jul 9.
3
Elderly-onset hereditary pulmonary alveolar proteinosis and its cytokine profile.
BMC Pulm Med. 2017 Feb 17;17(1):40. doi: 10.1186/s12890-017-0382-x.
4
Gene correction of human induced pluripotent stem cells repairs the cellular phenotype in pulmonary alveolar proteinosis.
Am J Respir Crit Care Med. 2014 Jan 15;189(2):167-82. doi: 10.1164/rccm.201306-1012OC.
5
Familial pulmonary alveolar proteinosis caused by mutations in CSF2RA.
J Exp Med. 2008 Nov 24;205(12):2703-10. doi: 10.1084/jem.20080990. Epub 2008 Oct 27.
6
Immune dysregulation in the pathogenesis of pulmonary alveolar proteinosis.
Curr Allergy Asthma Rep. 2010 Sep;10(5):320-5. doi: 10.1007/s11882-010-0134-y.
7
A murine model of hereditary pulmonary alveolar proteinosis caused by homozygous gene disruption.
Am J Physiol Lung Cell Mol Physiol. 2022 Mar 1;322(3):L438-L448. doi: 10.1152/ajplung.00175.2021. Epub 2022 Jan 19.
9
Long-Term Safety and Efficacy of Gene-Pulmonary Macrophage Transplantation Therapy of PAP in Csf2ra Mice.
Mol Ther. 2019 Sep 4;27(9):1597-1611. doi: 10.1016/j.ymthe.2019.06.010. Epub 2019 Jul 2.
10
Pulmonary alveolar proteinosis caused by deletion of the GM-CSFRalpha gene in the X chromosome pseudoautosomal region 1.
J Exp Med. 2008 Nov 24;205(12):2711-6. doi: 10.1084/jem.20080759. Epub 2008 Oct 27.

引用本文的文献

1
A murine model of hereditary pulmonary alveolar proteinosis caused by homozygous gene disruption.
Am J Physiol Lung Cell Mol Physiol. 2022 Mar 1;322(3):L438-L448. doi: 10.1152/ajplung.00175.2021. Epub 2022 Jan 19.
2
Alveolar proteinosis of genetic origins.
Eur Respir Rev. 2020 Oct 28;29(158). doi: 10.1183/16000617.0187-2019. Print 2020 Dec 31.
3
Pulmonary alveolarproteinosis in children.
Breathe (Sheff). 2020 Jun;16(2):200001. doi: 10.1183/20734735.0001-2020.
4
Uncovering Missing Heritability in Rare Diseases.
Genes (Basel). 2019 Apr 4;10(4):275. doi: 10.3390/genes10040275.

本文引用的文献

1
GM-CSF as a therapeutic target in autoimmune diseases.
Inflamm Regen. 2016 Jul 5;36:8. doi: 10.1186/s41232-016-0014-5. eCollection 2016.
2
Pulmonary Alveolar Proteinosis Syndrome.
Clin Chest Med. 2016 Sep;37(3):431-40. doi: 10.1016/j.ccm.2016.04.006. Epub 2016 Jun 17.
4
Characterization of CSF2RA mutation related juvenile pulmonary alveolar proteinosis.
Orphanet J Rare Dis. 2014 Nov 26;9:171. doi: 10.1186/s13023-014-0171-z.
5
Clinical interpretation and implications of whole-genome sequencing.
JAMA. 2014 Mar 12;311(10):1035-45. doi: 10.1001/jama.2014.1717.
6
TSLP signaling pathway map: a platform for analysis of TSLP-mediated signaling.
Database (Oxford). 2014 Feb 25;2014:bau007. doi: 10.1093/database/bau007. Print 2014.
8
Clinical whole-exome sequencing for the diagnosis of mendelian disorders.
N Engl J Med. 2013 Oct 17;369(16):1502-11. doi: 10.1056/NEJMoa1306555. Epub 2013 Oct 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验